RT Journal Article
SR Electronic
T1 Death by scientific method: Estimated mortality associated with the failure to conduct routine prospective cumulative systematic reviews in medicine and public health
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.20.20216242
DO 10.1101/2020.10.20.20216242
A1 Robert A. Hahn
A1 Steven M. Teutsch
YR 2020
UL http://medrxiv.org/content/early/2020/10/22/2020.10.20.20216242.abstract
AB Failure to routinely assess the state of knowledge as new studies accumulate results in 1) non-use of effective interventions, 2) continued use of ineffective or harmful interventions, and 3) unnecessary research. We use a published cumulative meta-analysis of interventions to reduce the harms of acute myocardial infarctions (1966-1992), and applied population attributable risk to assess the mortality consequences of the failure to cumulatively assess the state of knowledge. Failure to use knowledge that would have been available with cumulative meta-analysis may have resulted in annual estimated mortality: 41,000 deaths from non-use of intravenous dilators, 35,000 deaths from non-use of aspirin, and 37,000 deaths annually from non-use of ß-blockers. Continued use of Class 1 anti-arrhythmic drugs, which would have been found to be harmful in 1981, resulted 39,000 deaths annually. Failure to routinely update the state knowledge can have large health consequences. The process of building knowledge and practice in medicine and public health needs fundamental revision.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:naAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesavailable from author